Therapeutic potential of mycobacterial cell wall-DNA complexes (Q34481895)

2 August 2017

1 reference

title

Therapeutic potential of mycobacterial cell wall-DNA complexes (English)

1 reference

2 August 2017

1 reference

Filion MC

1

1 reference

2 August 2017

Phillips NC

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

2157-2165

1 reference

Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS)

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Intralesional immunotherapy of malignant melanoma with mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate (p3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Immunotherapy with nonviable microbial components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

An anti-neoplastic glycan isolated from Mycobacterium bovis (BCG vaccine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Interleukin-12 an integral cytokine in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Tumor-induced immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

The effects of therapeutic irradiation on lymphocytes and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Can cancer chemotherapy enhance the malignant behaviour of tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Cell death: the significance of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Mitochondria as the central control point of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Biological response modifiers for the treatment of superficial bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Are BCG effects against urinary bladder carcinoma cell line T24 correlated with apoptosis in vitro?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Immunotherapy of prostatic cancer with Bacillus Calmette-Guérin and purified protein derivative. Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Adjuvant immunotherapy with B.C.G. in carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Pro-apoptotic and immunomodulatory activity of a mycobacterial cell wall-DNA complex towards LNCaP prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.12.2157

10.1517/13543784.10.12.2157

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference